Impact of Rechallenge with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib

Impact of Rechallenge with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib

Purpose. This retrospective, nonrandomized study investigated the effect of imatinib rechallenge plus best supportive care (BSC) on overall survival after imatinib and sunitinib treatment for patients with locally advanced or metastatic gastrointestinal stromal tumor (GIST). Methods. Twenty-six pati...

Full description

Bibliographic Details
Main Authors:	Akira Sawaki, Tatsuo Kanda, Yoshito Komatsu, Toshirou Nishida
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	Gastroenterology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2014/342986

Similar Items

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib
by: Bruno Vincenzi, et al.
Published: (2018-08-01)

Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile?
by: Tielen Ronald, et al.
Published: (2012-06-01)

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study
by: Rutkowski Piotr, et al.
Published: (2012-03-01)

Response to imatinib rechallenge in a patient with a recurrent gastrointestinal stromal tumor after adjuvant therapy: a case report
by: Kang Yoon-Koo
Published: (2011-10-01)

Mechanisms of the resistance of gastrointestinal stromal tumors to imatinib
by: A R Galembikova, et al.
Published: (2018-12-01)

Update on imatinib for gastrointestinal stromal tumors: duration of treatment
by: Linch M, et al.
Published: (2013-07-01)

Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate
by: Omar S Din, et al.
Published: (2008-03-01)

The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)*
by: Piotr Rutkowski, et al.
Published: (2017-12-01)

Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumors
by: Damien Kee, et al.
Published: (2012-09-01)

SDH-deficient gastrointestinal stromal tumors: paradoxical effect of imatinib
by: Daria A. Filonenko, et al.
Published: (2020-07-01)

ZNF-mediated resistance to imatinib mesylate in gastrointestinal stromal tumor.
by: Lori Rink, et al.
Published: (2013-01-01)

Heterogeneity of Metabolic Vulnerability in Imatinib -Resistant Gastrointestinal Stromal Tumor
by: Wen-Kuan Huang, et al.
Published: (2020-05-01)

Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib
by: Richard Quek, et al.
Published: (2010-02-01)

Imatinib-induced podocytopathies in a patient with gastrointestinal stromal tumor
by: Gang Wang, et al.
Published: (2021-01-01)

A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failure
by: Xiao W, et al.
Published: (2018-05-01)

Spontaneous hemoperitoneum in recurrent jejunal gastrointestinal stromal tumor after imatinib therapy
by: Tzu-Chieh Yin
Published: (2013-07-01)

Chloroquine Combined with Imatinib Overcomes Imatinib Resistance in Gastrointestinal Stromal Tumors by Inhibiting Autophagy via the MAPK/ERK Pathway
by: Zheng S, et al.
Published: (2020-07-01)

Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
by: S. V. Boichuk, et al.
Published: (2015-06-01)

Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy
by: Gibbons Joseph, et al.
Published: (2009-03-01)

Rhabdomyosarcomatous Transformation of a Gastrointestinal Stromal Tumor following Treatment with Imatinib
by: Xiaoyin Jiang, et al.
Published: (2015-01-01)

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
by: Sumin Tang, et al.
Published: (2017-04-01)

Aurora kinase A (AURKA) promotes the progression and imatinib resistance of advanced gastrointestinal stromal tumors
by: Xiaobin Cheng, et al.
Published: (2021-07-01)

Imatinib Mesylate Therapy in Advanced Gastrointestinal Stromal Tumors: Experience from a Single Institute
by: Hui-Hua Hsiao, et al.
Published: (2006-12-01)

Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome
by: Shang-Yu Wang, et al.
Published: (2019-03-01)

Sarcomas del estroma gastrointestinal tratados con Imatinib®: presentación de 2 casos Gastrointestinal stromal tumors treated with Imatinib®: report of 2 cases
by: Mayté Lima, et al.
Published: (2006-06-01)

Hepatitis B Virus Reactivation in Gastrointestinal Stromal Tumor Patients Treated With Imatinib
by: Tianxiang Lei, et al.
Published: (2021-01-01)

Imatinib Mesylate: Past Successes and Future Challenges in the Treatment of Gastrointestinal Stromal Tumors
by: Doran Ksienski
Published: (2011-11-01)

Imatinib Mesylate: Past Successes and Future Challenges in the Treatment of Gastrointestinal Stromal Tumors
by: Doran Ksienski
Published: (2011-01-01)

Rapidly progressive dyspnea in gastrointestinal stromal tumor (GIST) with imatinib cardiac toxicity
by: Adnan Asif Parvez Ghias, et al.
Published: (2018-03-01)

Application of therapeutic drug monitoring of imatinib for individual treatment of gastrointestinal stromal tumor
by: Koji Fukuda, et al.
Published: (2016-06-01)

NEOADJUVANT IMATINIB AND RADIOTHERAPY IN GASTROINTESTINAL STROMAL TUMOR OF THE RECTUM: A CASE REPORT
by: Rocco Luca Emanuele Liardo
Published: (2015-04-01)

Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor
by: Chaoyong Shen, et al.
Published: (2014-11-01)

Imatinib-Resistant Gastrointestinal Stromal Tumor Presenting as a Large Abdominal Mass
by: Asim Haider, et al.
Published: (2021-08-01)

A rectal gastrointestinal stromal tumor—a plea for neoadjuvant imatinib and TAMIS
by: Jagan Balu, et al.
Published: (2020-01-01)

The Merendino procedure following preoperative imatinib mesylate for locally advanced gastrointestinal stromal tumor of the esophagogastric junction
by: Schwarzbach Matthias HM, et al.
Published: (2008-04-01)

Adjuvant and Down-Staging Treatment with Imatinib in Gastrointestinal Stromal Tumours
by: Andersson, Anna
Published: (2008)

Sigmoid Sinus Thrombosis Followed by Splenic Infarction Due to Imatinib Therapy in a Patient with Gastrointestinal Stromal Tumor; Hematological Side Effects of Imatinib
by: Hatice YILMAZ, et al.
Published: (2021-03-01)

Soft Tissue Calcification Secondary to Imatinib Mesylate in a Patient with Gastrointestinal Stromal Tumor
by: Enck, Robert E., et al.
Published: (2013)

Safety of Regular-Dose Imatinib Therapy in Patients with Gastrointestinal Stromal Tumors Undergoing Dialysis
by: Ryota Niikura, et al.
Published: (2016-05-01)

Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor
by: Hwang Jun-Eul, et al.
Published: (2010-08-01)